text:
wow such a huge thread for some thing so simple my mind boggles
Mods I posted something similar on on another tread it only had two posts but I just seen this and since its a problem
for most people id thought id repost it in the thread thats most warranted
to enable apps to run in root in ubuntu just recompile i see some people post is there a way to do it another way without recompiling
lol this is linux B**ches welcome to world of compiling dont be so lazy
This goes for all apps that dont run root as default the same apply's use the flag --enable-run-as-rootCode:wget -c http://download.videolan.org/pub/vid...0.9.9a.tar.bz2 tar -xvf vlc-0.9.9a.tar.bz2 cd vlc-0.9.9a apt-get build-dep vlc ./configure --enable-run-as-root make make install apt-get install libvlc-dev libvlc2
any problems please post and ill help you out its the proper way to do it forget messing with the hex values
THIS DOES WORK there two ways of doing things in linux the right way and the wrong way
messing with the program hex values is the WRONGWAY
recompiling with the proper flags and commands is the RIGHTWAY
Did you do apt-get remove --purge vlc
you must remove and rompile and remove any make sure there are no leftover vlc folders or files please with me the output is there are errors after make or make install
This is not an after though nor is it something I found somebody was trying to do and said it worked for them
this work hail rain or snow so in order to help and get this to work please display the output and error's
after you follow the guide whn you do "vlc" in the terminal what's the output ???????????
Info man info This is so important saying"this doesn't work or It doesn't work for me is nonsense we are both using the same distro"
so you have either lacking dependences or there's an error you need to resolve
Code:--2011-06-18 10:27:29-- http://download.videolan.org/pub/vid...0.9.9a.tar.bz2 Resolving download.videolan.org... 188.8.131.52 Connecting to download.videolan.org|188.8.131.52|:80... connected. HTTP request sent, awaiting response... 404 Not Found 2011-06-18 10:27:30 ERROR 404: Not Found.
what can i do ?? many thanks
thanks cgelici,
but qhent is right....is not "geteuid._libc_start_man", but "geteuid._libc_start_main"...
thanx, i would rather go the more command intensive direction since I am learning Linux and it's distros.
I prefer to adding a non-root user and edit the kde menus mannually to run vlc or Chrome as the non-root user...
People should choose whatever they want. I just offered 1 solution... And about the tweak, the only thing that changes is vlc is checking ppid instead of geteuid, it's not a major modification...
Code:wget http://download.videolan.org/pub/videolan/vlc/1.1.9/vlc-1.1.9.tar.bz2 tar -xvf vlc-1.1.9.tar.bz2 cd vlc-1.1.9 apt-get build-dep vlc ./configure --enable-run-as-root make make install apt-get install libvlc-dev libvlc2
thank you very very much!!! i was installed vlc and it didn't work....now it work because the hex change.....thank you!!!!! (sorry for my low english)


text:
'"We felt it was very important to sign Paul to a multi-year deal at this stage of his career," Buffalo general manager Darcy Regier said. "He has become an integral part of our team both on and off the ice in the past three years."'
Sabres sign C Gaustad to four-year contract
June 30, 2008 Submitted by
Via: The Sports Network

subset: commoncrawl


text:
HER2-Directed Therapy for Metastatic Breast Cancer
HER2-Directed Therapy for Metastatic Breast Cancer
Human epidermal growth factor receptor 2 (HER2) overexpression drives the biology of 20% of breast cancers, and predicts a poor prognosis for patients. HER2-targeted therapies significantly improve outcomes for HER2-positive patients with both early and metastatic breast cancer. Currently three HER2-targeted agents, trastuzumab (Herceptin), lapatinib (Tykerb), and pertuzumab (Perjeta), are available for the treatment of HER2-positive metastatic breast cancer (MBC). Numerous studies have attempted to optimize their use by combining them with each other, or with endocrine and cytotoxic therapies. Most recently, the FDA approved the combination of trastuzumab, pertuzumab, and docetaxel as first-line treatment for MBC, and in late February 2013 approved a fourth HER2-targeted agent, trastuzumab emtansine (T-DM1, Kadcyla), for accelerated approval. These advances create a number of clinical dilemmas, including identification of the optimal sequence of HER2-targeted agents and the best drug combinations to use, as well as the recognition of primary and acquired drug resistance. In this article, we review clinical data informing the effective management of HER2-positive MBC.
The human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase that is overexpressed in approximately 20% of invasive breast cancers, primarily due to gene amplification.[1] HER2 overexpression is clearly associated with more aggressive disease and worse clinical outcomes.[2] Importantly, HER2 overexpression strongly predicts response to HER2-targeted therapies, highlighting the importance of accurately defining the level of HER2 expression in both primary and metastatic tumors. Multiple studies have shown discordance in HER2 expression levels in up to 25% of paired primary and metastatic breast cancers,[3-5] and a substantial proportion of women with HER2-negative primary tumors acquire HER2 protein overexpression in their tumors at the time of relapse.[6-8] In patients with metastatic breast cancer (MBC), accurate determination of HER2 status is thus critical for guiding treatment decisions. The National Comprehensive Cancer Network (NCCN) guidelines recommend HER2 testing at relapse, particularly if HER2 expression was originally unknown or negative.[9]
Over the last 15 years, several HER2-targeted therapies have been developed, including HER2-specific monoclonal antibodies that bind to the external domain of the molecule (trastuzumab [Herceptin] and pertuzumab [Perjeta]), small-molecule tyrosine kinase inhibitors that inhibit signaling within the cell (lapatinib [Tykerb], neratinib [HKI-272], and afatinib [BIBW 2992]), and HER2-specific monoclonal antibodies conjugated to cytotoxic molecules (trastuzumab emtansine [T-DM1, Kadcyla]). Currently, four of these HER2-targeted agents are approved by the US Food and Drug Administration (FDA) for use: trastuzumab, lapatinib, pertuzumab, and T-DM1, with the last approved in February of this year. Here we review these HER2-targeted therapies, and discuss novel, promising agents for treatment of HER2-positive MBC that may become available in the next few years.
The first HER2-targeted therapy approved by the FDA is trastuzumab, a humanized monoclonal antibody (IgG1) that binds to the extracellular domain of HER2. It has preferential activity against breast cancers driven by HER2 homodimers.[10] Since receiving FDA approval in 1998, trastuzumab has become clearly established as the key component of treatment for HER2-positive breast cancer in both the adjuvant and metastatic settings.[11-17] The addition of trastuzumab to chemotherapy is associated with significant improvement in time to tumor progression (TTP), objective response rate (ORR), duration of response, and overall survival (OS) in patients with HER2-positive MBC.[15] Patients with metastatic HER2-positive tumors may derive benefit from treatment with trastuzumab as a single agent, or in combination with cytotoxic or endocrine therapy.
Trastuzumab as a single agent in metastatic disease
Two seminal trials of single agent trastuzumab in the metastatic setting tested a weekly schedule, demonstrating moderate clinical activity with response rates (RR) of 15% to 34%[16,17] (Table 1). The most common adverse events were infusion-related, and cardiac dysfunction was reported in 2% to 4.7% of patients in these early studies.[16,17] A third phase II study evaluated the administration of trastuzumab every 3 weeks for the first-line treatment of HER2-positive MBC in 105 patients. Here, the ORR was 23% and the clinical benefit rate (CBR) was 36% (Table 1).[18] Single-agent trastuzumab given every 3 weeks was therefore shown to be effective, safe, and convenient.
Trastuzumab with chemotherapy in metastatic disease
Preclinical data have suggested potential additive or synergistic effects with trastuzumab and multiple cytotoxic agents, including anthracyclines, taxanes, vinorelbine, and cyclophosphamide.[19] In a pivotal multinational phase III clinical trial of 469 patients with previously untreated HER2-positive MBC, women treated with anthracyclines in the adjuvant setting were randomized to paclitaxel with or without trastuzumab, whereas anthracycline-naive patients were randomized to anthracycline-based chemotherapy with or without trastuzumab.[15] Compared with chemotherapy alone, trastuzumab plus any chemotherapy was associated with a longer median TTP (7.4 vs 4.6 months; P < .001), higher ORR (50% vs 32%; P < .001), and longer median OS (25 vs 20 months; P = .046) (Table 1). The rate of cardiotoxicity was increased with the addition of trastuzumab to chemotherapy, particularly in patients receiving anthracyclines with trastuzumab (27% cardiotoxicity vs 8% with anthracycline chemotherapy alone) as compared to paclitaxel with trastuzumab (18% cardiotoxicity vs 1% with paclitaxel chemotherapy alone). Because of significant cardiotoxicity, this trial established that the combination of anthracyclines and trastuzumab cannot be recommended for patients with MBC. Compared with paclitaxel alone, trastuzumab plus paclitaxel was associated with a significant improvement in ORR (38% vs 16%; P < .001), a longer median TTP (7 vs 3 months; P < .001), and a trend toward a longer median OS (22 vs 18 months; P = .17). It is notable that 72% of patients who received chemotherapy alone on this trial crossed over to receive trastuzumab. Thus, the survival benefit of trastuzumab-based chemotherapy is probably underestimated in this study.
Multiple phase II trials have evaluated the combination of different chemotherapeutic agents given with trastuzumab for metastatic disease.[20] Of these combinations, docetaxel plus trastuzumab has the highest activity against metastatic disease, with response rates of 50% to 76% and a favorable toxicity profile.[21-25] In a randomized, multicenter, phase II trial, docetaxel plus trastuzumab was significantly more effective than trastuzumab alone with respect to ORR (61% vs 34%; P = .0002), median TTP (12 vs 6 months; P = .0001), and median OS (31 vs 23 months; P = .0325), and was not associated with a substantial increase in toxicity.[24] In vitro data have suggested that trastuzumab may reverse platinum resistance by modulating HER2 activity.[26] Based on this rationale, a phase III trial enrolled 196 patients with HER2-positive MBC, randomly assigning them to 6 cycles of treatment with trastuzumab plus paclitaxel with or without carboplatin.[27] The three-drug combination was significantly more effective than the two-drug combination with respect to ORR (52% vs 36%; P = .04) and median progression-free survival (PFS) (10.7 vs 7.1 months; P = .03), but not OS (35.7 vs 32.2 months).[27] In contrast to these results, the randomized phase III Breast Cancer International Research Group (BCIRG) 007 trial of 263 patients with previously untreated MBC did not show a benefit with the addition of carboplatin to docetaxel and trastuzumab.[28] Trastuzumab has also been shown to be effective in combination with vinorelbine. In the TRAVIOTA (trastuzumab and vinorelbine or taxane) study, 81 patients with previously untreated HER2-positive MBC were randomly assigned to trastuzumab plus weekly vinorelbine or taxane therapy.[29] The two regimens had comparable efficacy, with safety differences as expected for the different agents. Most recently, the HERNATA (Herceptin Plus Navelbine or Taxotere) trial compared docetaxel plus trastuzumab to vinorelbine plus trastuzumab in 284 chemotherapy-naive MBC patients.[30] There was no difference in OR (59.3% in both groups); however, more patients in the docetaxel arm discontinued therapy due to toxicity (P < .001). The combination of trastuzumab and capecitabine (Xeloda) has also shown efficacy as a first-line trastuzumab-containing regimen in this patient population.[31,32]
Trastuzumab with endocrine therapy in metastatic disease
Several studies have shown that HER2-targeted therapy is beneficial when added to an aromatase inhibitor in patients with hormone receptor (HR)-positive, HER2-positive MBC (Table 2). In the randomized, placebo-controlled, open-label, multicenter phase III TAnDEM (Trastuzumab in Dual HER2 ER-positive Metastatic breast cancer) trial, 208 postmenopausal patients with HER2-positive and estrogen receptor (ER)- and/or progesterone receptor (PR)-positive disease were randomly assigned to anastrozole (Arimidex) alone or with weekly trastuzumab until disease progression.[33] Anastrozole plus trastuzumab was significantly more effective than anastrozole alone with regard to both ORR (20% vs 7%, P = .018) and median PFS (4.8 vs 2.4 months; P = .0016). OS was not significantly different (28.5 months for anastrozole plus trastuzumab vs 23.9 months for anastrozole alone; P = .325); however, 70% of patients in the anastrozole-alone arm crossed over to receive trastuzumab after progression on anastrozole.[33] Cardiac dysfunction developed in 14 out of 103 patients (14%) receiving trastuzumab plus anastrozole and in 2 out of 104 patients (2%) treated with anastrozole alone, but grade 3 or 4 events were balanced between the treatment groups. Nearly 15% of patients who received anastrozole plus trastuzumab did not experience disease progression for at least 2 years, suggesting that concurrent hormonal therapy with trastuzumab can delay chemotherapy in some patients. In the eLEcTRA trial (Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer), 57 patients were randomized to either letrozole (Femara) or letrozole plus trastuzumab. Median TTP was 3.3 months vs 14.1 months (hazard ratio [HR] = 0.67; P = .23), and ORR was 13% vs 27% in the letrozole and letrozole plus trastuzumab arms, respectively.[34]
Trastuzumab beyond disease progression
An issue that has emerged since the initial trials of trastuzumab is how to best manage patients whose tumors progress while on trastuzumab-based therapy. Several recent trials have demonstrated benefit with continuing trastuzumab therapy following disease progression on a trastuzumab-containing regimen.[35,36] One phase III study investigated capecitabine with or without trastuzumab in patients who had progressed on trastuzumab. Although the trial was closed prematurely due to poor accrual, data from the available 156 patients showed no significant difference in OS with capecitabine vs capecitabine plus trastuzumab, with OS of 20.6 months and 24.9 months, respectively (HR = 0.94; P = .73).[37] Final OS analysis of the German Breast Group GBG-26 study did not demonstrate a significant survival benefit for treatment beyond progression with trastuzumab. However, in a post-hoc analysis, patients receiving anti-HER2 treatment as third-line therapy showed a better post-progression survival than those who did not receive HER2-targeted treatment. A total of 52 patients who continued or restarted anti-HER2 treatment (trastuzumab or lapatinib) after their second progression had a post-progression survival of 18.8 months compared with 13.3 months for 88 patients who did not receive third-line treatment with anti-HER2 agents (HR = 0.63; P = .02). Continuation of trastuzumab was not associated with increased toxicity. These data together support use of HER2-targeted therapy beyond progression of disease for patients being treated with trastuzumab.
The second HER2-targeted therapy to receive FDA approval was lapatinib, originally designed as a dual HER2 and epidermal growth factor receptor (EGFR; also known as HER1) tyrosine kinase inhibitor.[38] Clinical studies showed that lapatinib reversibly inhibits the intracellular tyrosine kinase activity of HER2 primarily, blocking tyrosine kinase phosphorylation and thereby signaling pathways downstream of HER2. In vitro studies demonstrated significant activity of lapatinib in trastuzumab-resistant breast cancer cell lines, and early clinical trials suggested that lapatinib is active in both inflammatory breast cancer and trastuzumab-refractory disease.[39-41] Randomized trials evaluated lapatinib as first-line therapy in MBC. In a single-arm phase II study, 138 patients with HER2-positive previously untreated MBC were randomly assigned to one of two lapatinib doses (1500 mg once daily or 500 mg twice daily).[42] Single-agent lapatinib was associated with an ORR of 24% and a CBR of 31%. The median duration of response was 28.4 weeks, and the treatment was well tolerated. The main toxicities associated with lapatinib were diarrhea, acneiform rash, nausea, and pruritus. There was no apparent correlation noted between the development of the rash and the efficacy of lapatinib.[43] Lapatinib was finally approved by the FDA in 2007 based on an improvement in TTP and ORR when added to capecitabine in patients with advanced breast cancer who had been previously treated with anthracyclines and taxanes and had progressed on trastuzumab-based therapy.[44,45] In a randomized phase III trial, 399 women with HER2-positive advanced disease or MBC refractory to trastuzumab received capecitabine with or without lapatinib (Table 3).[45] The combination of capecitabine plus lapatinib was associated with significant improvements in TTP (6.2 vs 4.3 months; P < .001) and ORR (24% vs 14%; P = .017), and a reduction in the risk for central nervous system (CNS) metastasis (6% vs 2%; P = .045) compared with capecitabine alone. Moreover, there was no increase in serious side effects.
Like trastuzumab, lapatinib has been evaluated in combination with endocrine therapy. A double-blind, placebo-controlled phase III trial tested letrozole plus lapatinib compared with letrozole alone in 1,286 postmenopausal women with HR-positive MBC (Table 2). Among the subset of 219 patients with HER2-positive disease, the addition of lapatinib to letrozole was associated with a significant improvement in PFS compared with letrozole alone (8.2 vs 3.0 months; P = .019), but not OS (33.3 vs 32.3 months; P = .113).[46]
The development of brain metastasis is devastating, and occurs in about 35% of HER2-positive MBC patients treated with trastuzumab.[47] Unlike trastuzumab (a large protein), lapatinib (a small molecule) can cross the blood-brain barrier. In a single-arm phase II, open-label, multicenter study, 45 patients with HER2-positive MBC with brain metastases not previously treated with whole brain radiation (WBRT) received lapatinib plus capecitabine as first-line treatment of brain metastases. After a median follow-up of 21 months, 29 patients (66%) had an objective CNS partial response; the median TTP was 6 months, and the median time to WBRT was 8 months. Half of the patients on study had grade 3 or 4 treatment-related adverse events, of which the most common were diarrhea and hand-foot syndrome.[48]
A treatment approach based on the dual targeting of HER2 without the use of chemotherapy is of great interest. One strategy is to use trastuzumab to abrogate signaling through cell-surface interactions, and lapatinib to abrogate signaling at the inner surface of the cell membrane (upstream/downstream signaling inhibition). A recent randomized trial in 296 heavily pretreated patients with MBC and disease progression on trastuzumab tested the clinical activity of lapatinib vs lapatinib plus trastuzumab. Compared with lapatinib alone, lapatinib plus trastuzumab was associated with a significant improvement in PFS (12 vs 8 weeks; HR = 0.73; P = .008) and CBR (24.7% vs 12%; P = .01).[49] The most frequent adverse events were diarrhea, rash, nausea, and fatigue. Diarrhea was significantly higher in the combination arm compared with the lapatinib arm (60% vs 48%; P = .03). The incidence of symptomatic cardiac events was low, with 3.4% in the combination arm and 1.4% in lapatinib arm. Thus, despite disease progression on prior trastuzumab-based therapy, the addition of lapatinib to trastuzumab significantly improved PFS and CBR compared with lapatinib alone, offering a chemotherapy-free option to patients with HER2-positive MBC.
Pertuzumab is a humanized monoclonal antibody (IgG1) recently approved by the FDA for the first-line treatment of HER2-positive MBC in combination with trastuzumab and docetaxel. Like trastuzumab, pertuzumab binds to the extracellular domain of HER2, but at a different epitope, blocking the dimerization of HER2 with other HER family receptors and inhibiting downstream signaling.[50] In a study of 29 patients with HER2-positive MBC who progressed on trastuzumab-based therapy, single-agent pertuzumab therapy had modest activity, with an ORR of 3.4% and a CBR of 10.3%.[51] Trastuzumab was added to pertuzumab in 17 patients at disease progression, yielding an ORR of 17.6% and a CBR of 41.2%.[51] Consistent with this clinical observation, dual blockade of HER2 signaling at the cell surface resulted in greater antitumor activity in preclinical studies.[52] On the basis of these preclinical and clinical data, the combination of pertuzumab and trastuzumab was evaluated in a phase II trial of 66 patients with HER2-positive MBC who had progressed while on trastuzumab. The regimen was active, with an ORR of 24.2%, CBR of 50%, and PFS of 5.5 months.[53] Moreover, the toxicity of the combination was acceptable, with only three patients (5%) experiencing an asymptomatic decrease in ejection fraction. The most common side effects were diarrhea, fatigue, nausea, and rash. These findings once again raise interest in dual HER2 blockade without the use of cytotoxic chemotherapy, in this case with both agents acting at the extracellular cell surface.
The phase III CLEOPATRA (CLinical Evaluation Of Pertuzumab And TRAstuzumab) study was a randomized, double-blind, placebo-controlled international clinical trial that tested pertuzumab in combination with trastuzumab and docetaxel for the first-line treatment of patients with HER2-positive MBC.[54] This study randomized 808 previously untreated HER2-positive MBC patients to pertuzumab with trastuzumab and docetaxel or placebo with trastuzumab and docetaxel (Table 3). Less than half of the patients had received adjuvant or neoadjuvant chemotherapy, and only 11% of patients had been treated with trastuzumab in either the adjuvant or neoadjuvant setting. PFS was significantly improved in the pertuzumab group, with a PFS of 18.5 months compared with 12.4 months in the control group (HR = 0.62; P < .001). The interim analysis of OS was performed after 43% of prespecified total numbers were available for the final analysis, and there was a strong trend in favor of the pertuzumab arm. Although the number of patients who had received prior trastuzumab-containing adjuvant or neoadjuvant chemotherapy was small, the PFS benefit of adding pertuzumab to therapy for those patients was similar to the benefit observed in patients who had received prior adjuvant or neoadjuvant chemotherapy without trastuzumab. The safety profile was generally similar, with no increase in left ventricular systolic dysfunction. Grade 3 or higher left ventricular systolic dysfunction was reported in 2.8% of patients in the control group, and in 1.2% of patients treated with pertuzumab. In the pertuzumab group, there was more grade 3 febrile neutropenia (13.8% vs 7.6% in control group) and diarrhea (7.9% vs 5%). Based on these data, in June 2012, combination therapy with pertuzumab, trastuzumab, and docetaxel was approved by the FDA for first-line treatment of HER2-positive MBC.
Ongoing trials in HER2-positive MBC are currently evaluating pertuzumab in combination with trastuzumab and capecitabine in a phase II study in the second-line setting (PHEREXA [Capecitabine With or Without Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer]; NCT01026142), and in combination with trastuzumab emtansine (T-DM1) compared to trastuzumab and a taxane (docetaxel or paclitaxel) or T-DM1 alone in a phase III study in the first-line setting (MARIANNE [A Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab (Herceptin) Plus a Taxane in Patients With Metastatic Breast Cancer]; NCT01120184).


text: NEW YORK ( TheStreet) -- From hotel rooms and dinners out to bar tabs and room service, it's easy for a two-day business trip to turn into a $1,000 proposition. For many small businesses, entertaining new clients and visiting vendors is a part of life -- but so is managing costs. If you're interested in ensuring that your employees do "more with less" while on the road, you're not alone. Our experts weigh in on the best ways to prevent expensive expenses. Before you can complain about a hefty expense report, you have to make sure employees understand what they're allowed to buy, how they are expected to travel and the type of places they are encouraged to stay and dine, says Elaine Varelas, managing partner at outplacement and career services firm Keystone Associates. "For some companies, $10 is an enormous expenditure, and for others, you've got to hit the $1,000 mark before it even gets on their radar," Varelas says. "Managers have to be clear when conveying expectations." Anytime a manager sends someone out on the road for the first time, they need to give that employee an overview of what is expected and how much they should look to spend, Varelas says. Employees don't need to leave the office until they have a dollar figure in mind, as well as suggestions on restaurants and hotels that are within the company budget. Smart employees traveling for the first time will ask for recommendations, Varelas says, which can open up a broader dialogue. "It's ideal if they ask, 'Which restaurant would you recommend I take our client to?'" and you can either say, 'Don't go overboard' or 'Don't be afraid to go up a grade with this client,'" she says. While some companies offer strict per diem allowances for lodging and food, Varelas says she's "not thrilled" with that idea, simply because costs vary so widely from city to city. "Markets can be so significantly different for food and hotels that most managers may want to offer a cost range. In Buffalo, dinner might cost $35, but in Boston, it's probably going to be $60. The important thing is that you have those conversations in advance so no one is surprised," she says.


text:
A 14-year-old boy from Cedar Hills died Tuesday after being run over by a trailer at a Boy Scout camp in central Utah.
Bruce "Rocky" Rhiddlehoover was working as a volunteer at Tifie Scout Camp when he died Tuesday, confirmed Dan Gallup, a member of the Cedar Hills LDS Stake Presidency and spokesman for the boy's family.
Rhiddlehoover was helping clean up and haul trash at Tifie Scout Camp at the Mountain Dell Scout Ranch around 8 p.m. Tuesday when he apparently slipped or fell under the wheels of the trailer, which was being pulled by a pickup, said Sanpete County sheriff's Deputy Mark Lambert.
Several hundred Scouts remained at the camp on Wednesday and the BSA reportedly was bringing in grief counselors to help any boys struggling with the tragedy, according to David Pack, Scout Executive/CO at Utah National Parks Council of the Boy Scouts of America.
Pack said Rhiddlehoover was "an excellent scout," was close to earning Eagle Scout status, and had recently begun training as a camp counselor.
"He was in what we call our 'counselor-in-training' program," Pack said. "The accident occurred while he was doing regular staff duty, helping clean up trash around the camp."
Pack confirmed that the boy died at the scene of the accident after repeated efforts to revive him, including CPR by both camp staffers and Sanpete County emergency medical responders.
"He was a wonderful young man," Gallup said. "He was just always very inclusive, pulling other young men around him in and helping them to feel like they're part of the group."
In addition to scouting, Rhiddlehoover "loved music" and was learning to play the trumpet and tenor saxophone. He excelled in science and math classes, Gallup said.
Rhiddlehoover completed eighth grade in the spring at Mountain Ridge Junior High School in Highland. His parents are Bruce and Janice Rhiddlehoover; he has 11 adult siblings, Gallup said.
Twitter: @remims The funeral for Bruce "Rocky" Rhiddlehoover is scheduled for Monday at the LDS Cedar Hills Utah Stake Center, 3950 W Cedar Hills Drive. A viewing will take place 9:30 a.m. to 10:30 a.m. with a service at 11 a.m. Internment will be at American Fork Cemetery; Warenski Funeral Home is handling arrangements.
The family is accepting donations to the Rocky Rhiddlehoover Memorial Fund at Mountain America Credit Union. Proceeds will go toward finishing Rhiddlehoover's Eagle Scout project: school kits for needy children in Chad.


text:
The deal
- Package A for $148 (rrp. $2,500)
- Package B for $338 (rrp. $7,500)
- Package C for $398 (rrp. $7,780)
Package includes
- Choose 1 treatment (package A) / choose 3 treatments (package B or C):
- Bioline Most Hydrating treatment
- Bioline Perfect Age treatment
- Bioline purifying treatment
- Bioline Sweet Relief treatment
- Regenerator hydrating treatment
- Caviar oxygen treatment
- RF facial treatment
- Lymph body treatment
- Magnetic fork slimming treatment
- Vacuum photon RF treatment for eye
- Whitening eye care treatment
Customers who purchased package C get Y.U.E multi-vitamin whitening eye patches. (8pcs)
P.E.N. is an acronym for 'Pulito e Natura', which means 'natural and purity'. The company specialises in producing products that aim to eliminate external impurities and keeping the body clean with natural resources and materials. These items range from serums, massage oils, toners, creams, and more. Besides that, the beauty salon also offers a number of treatments like vitamin C whitening facial, collagen firming treatment, and Bioline Perfect Age treatment.


text:
Unless you've been sitting in a windowless data center for the past year, staring at the blinking lights and shunning a Web browser, you've probably noticed that not very many people are holding out hope for Windows 8's success. In fact, many quite knowledgeable people are fairly shocked that the Redmond giant is not wavering in the face of nearly universal disdain for the upcoming release of its flagship product. I mean, when even your friends point out your potentially gargantuan mistake, it's a good time to listen.
Then again, everyone laughed at the iPhone and the iPad, and look what happened there. Of course, it could be that the iPhone and iPad were actually compelling products with extremely well-designed interfaces and an amazingly well-thought-out ecosystem behind them. But this is Microsoft we're talking about.
[ Also on InfoWorld: Windows 8 review: Yes, it's that bad | The case for Windows 8 | Get expert advice about planning and implementing your BYOD strategy with InfoWorld's 29-page"Mobile and BYOD Deep Dive" PDF special report. | Keep up on key mobile developments and insights with theMobilize newsletter. ]
We might see any of a number of different scenarios play out in the next six to 12 months. One is that Windows 8 will be a roaring success, smashing all kinds of sales records and vanquishing XP, Vista, and Windows 7 to the scrap heap. No, I don't think so either.
A second is that Windows 8 does as well as Windows 7, not burning down the house, but quickly becoming a generally accepted and lauded OS that provides Microsoft with a nice win and its first back-to-back OS successes. This, sadly, is equally unlikely.
A third scenario is that Windows 8 follows the path of Vista, which is to say it's fairly horrible, leading organizations that quickly jump on it to regret the decision later -- just as Vista's early adopters soon realized that they had to do it all over again because Windows 7 showed up and actually worked. Microsoft's inertia being what it is, this is the most likely scenario. Believe me, those who hopped on Vista won't be doing the same for Windows 8. They'll be waiting for the next release. Once bitten, after all.
A fourth scenario: Windows 8 ultimately costs Microsoft the farm. I can imagine the meetings that were held in Redmond where executives, designers, and engineers discussed how the next version of Windows should look. I suppose that someone was fervently pushing the idea of bringing a common UI to all devices: tablets, smartphones, and the PC. By getting this common UI philosophy into the brains of consumer and corporation alike, it would be a huge win, and not just along the lines of what Apple has done, but actually a step further in some respects. However, they missed a key element that Apple did not: Make the UI equally usable and elegant for all of those hardware platforms.
I expect plenty of people in those meetings argued that the traditional Start button should remain available, and there should be a "classic" mode to allow longtime Windows users to feel at home. Those reasonable people were outvoted, presumably due to the misguided thinking that if Microsoft offered a way back, then too many users would stick with the old and the whole Metro push would fail. Frankly, it's probably true that most people would cling to a classic desktop, but they'd have Metro available to them as well.


text:
'A local public corporation that would oversee the nearly one (b) billion-dollar development of the Buffalo waterfront is expected to be created as early as next week. And Sabres Managing Partner Larry Quinn is likely to head it, The Buffalo News reports.'
Sabres partner may lead Buffalo waterfront group
July 1, 2005 Submitted by
Via: AP


text:
If you read Baron's post above yours, you'll see he's thinking that the dude that processes that information is out of town.
No, it does not usually take that long....
i got my email today!!!!!
Same here, does anyone know what kinda caps come in the 50 Free Tips shit? I hope they got some female rusto fats and german outlines in there
im pretty sure u can pick what caps you want man?
Hey everybody, I'm from midwest Canada and i'm still a toy but my main interests are stickers, markers and stenciling, but I plan to move up to some wheatpastes and maybe some freestyles eventually once I'm good enough. I'm also into longboarding which goes hand in hand with street art, same environment for the most part
i was tryina do some freestyles but i aint even good enough yet tho
eventualy ima move up from freestyles to wheat pasting tho
aim : jawnMcCain
Hello. I'm brand new to graff. Guilty (of being a toy) until proven innocent. IMO, Colour is anus...greyscale ftw!
^ wouldnt that get old quick though?
booooorrrriinnnnnnn ZZZZZZZZZzzZzZZzzZZZZzzzZZZZzzZ
Maybe usually they let you pick the caps, but in my case I think I got twenty five NY skinny and twenty five NY fats.
I think they did that because....
I got sick of waiting for the email so I ordered 9 cans of ironlak, then like five hours before it shipped out, the dude emailed me back, and I asked him if it was possible to put the fifty caps with my paint. I didnt think he was gonna be able to but surprisingly he emailed me back five minutes later and said that he could. Kinda sucks that they're all NY fats n skinnys, I was looking forward to having an astro fat.
I don't really buy stupid caps, I like orange dots and banana skinny/ german outline... so i was excited to try out some new shit lol
I just moved from L.A. to NYC, just a young bomber looking to get my feet wet in the New York scene. Hmu to help out with how I can acquire supplies.
yo yo 216 cleveland Prose whats good?
Check out my stickers/first throwie Flickr.com/label_228
Yo, greetings from switzerland! I write DAP and if anyone is in zurich that knows some good spots I may not know msg me.
greets from holland
hey i had a question about paint when I'm throwing up shit on a building i never know how far to keep my can from the wall some times i put it to close and its drippy and sometimes to far and its too faded how many inches i should keep it thanks ?
also does anyone know any good stores for supplies in mtl theres online an shit but I'm 15 i cat order online my parents would find out thanks again
where in canada I'm a great ongboarder and I'm still a toy I'm looking to get together with some people the same skill level as me and go bomb some places up i live in mtl hit me up


text:
Orlando, Fla. • Aaron Murray wanted nothing more this week than to send Georgia's senior class out with a game to remember.
The junior quarterback provided a record-setting performance to make it a reality.
Murray threw five touchdown passes to set a Georgia bowl record, including two in the fourth quarter, as the sixth-ranked Bulldogs beat No. 23 Nebraska 45-31 in the Capital One Bowl on Tuesday.
Murray shook off a pair of first-half interceptions, including one returned for a touchdown, and passed for 427 yards also a Bulldogs bowl record against the nation's top-ranked passing defense. He was the game's most valuable player on the way to earning his first bowl victory at Georgia.
Georgia (12-2) also reached 12 wins for the third time in school history.
"I don't know what it's like to head into an offseason with a win," Murray said. "It's a great feeling to get a win. It's great for the seniors, who have meant so much to this team. They've done a great job of leading this team the whole season.
"To get 12 wins ...that's something special."
Nebraska (10-4) lost its third consecutive bowl game, and finished the season with two straight woeful defensive performances. The Cornhuskers lost the Big Ten championship game 70-31.
The Cornhuskers led 24-23 at the half but committed two of their three turnovers in the final 30 minutes.
Taylor Martinez had two interceptions and two touchdown passes for Nebraska, and Rex Burkhead rushed for 140 yards in his final college game.
But Nebraska coach Bo Pelini said the efficiency of Murray and Georgia on third down (finished 12 for 17) was too much to overcome.
"I thought the plan was good," Pelini said of his team's defensive scheme. "Third down hurt us, obviously. When were in position, it was man on man down the field. We needed to make some of those plays and we didn't. And, you know, again, that cost us a football game."
Nebraska drops to 12-7 against SEC opponents in bowl games.
Trailed by questions about his team's focus following its narrow loss to Alabama in the SEC championship game, Georgia coach Mark Richt said Tuesday was also about a team that finished 5 yards shy of a BCS title game-berth finding closure.
"We wanted to win this game to prove to ourselves that we are one of the better teams in the country," Richt said. "I think our guys did a good job of sucking it up when they were tired...But when you make a big play here and there, it gives you a little more energy as well...We made enough big plays at the right moment."
Nebraska's offense finished with 443 total yards, but the Bulldogs defense was stingy when it needed to be.
They sacked Martinez five times, with junior All-American linebacker Jarvis Jones notching two. Damian Swann had both Georgia interceptions.
With his two sacks Jones set a single-season record for with 14.5 sacks for the season. He will now decide in the coming days whether or not to enter the NFL draft.
"I think our coaches did a great job of halftime adjustments and got us out there adjusting to what they were calling and got us players honed in," Jones said.
No. 6 Georgia 45, No. 23 Nebraska 31
Georgia 16 7 8 14 45
Nebraska 14 10 7 0 31
First Quarter
Geo • Safety, 11:39.
Geo • Lynch 29 pass from Murray (Morgan kick), 7:54.
Neb • Turner 14 pass from Martinez (Maher kick), 4:42.
Neb • Compton 24 interception return (Maher kick), 4:15.
Geo • King 75 pass from Murray (Morgan kick), 4:04.
Second Quarter
Geo • Gurley 24 run (Morgan kick), 10:33.
Neb • FG Maher 39, 8:48.
Neb • Burkhead 16 pass from Martinez (Maher kick), 4:43.
Third Quarter
Neb • Burkhead 2 run (Maher kick), 9:42.
Geo • Conley 49 pass from Murray (McGowan pass from Murray), 7:26.
Fourth Quarter
Geo • Marshall 24 pass from Murray (Morgan kick), 14:52.
Geo • Conley 87 pass from Murray (Morgan kick), 11:03.
Attendance • 59,712.
Geo Neb
First downs 23 26
Rushes-yards 38-162 52-239
Passing 427 204
Comp-Att-Int 18-33-2 16-27-2
Return Yards 89 42
Punts-Avg. 3-39.0 4-34.0
Fumbles-Lost 0-0 1-1
Penalties-yards 7-76 8-69
Time of Possession 27:33 32:27
Individual Statistics
Rushing • Georgia, Gurley 23-125, Marshall 8-36, Murray 4-3, King 1-0, Team 2-(minus 2). Nebraska, Burkhead 24-140, Abdullah 7-48, Martinez 20-46, Heard 1-5.
Passing • Georgia, Murray 18-33-2-427. Nebraska,
Martinez 16-27-2-204.
Receiving • Georgia, King 3-104, Scott-Wesley 3-67, McGowan 3-40, Marshall 3-39, Lynch 3-37, Conley 2-136, Gurley 1-4. Nebraska, K.Bell 4-60, Burkhead 4-39, Turner 3-22, B.Cotton 2-69, Enunwa 2-11, Reed 1-3.


text:
Would you like to save as your currency permanently or for this visit only?
Airport shuttle
I stayed here for 12 days and found it as my second home away from my home. Excellent service and professional staff. I am proud to recommend anyone. Perfect Place to stay
I am really impressed by the personalized service. It was a wonderful experience
I stayed at Karachi Marriott in March 2008. It was a huge disappointment for me. \nI had a booking for the normal standard room but the receptionist kept on insisting for me to upgrade myself to their executive floor by paying some extra amount. Clearly I wasn't interested but he took 10 mins of my time trying to convince me for no reason. When I finally entered the room, the air conditioning of the room was not working. Had to move to another room then, in which there were no TV remote control. Had to ask for it thrice after which it reached my room after 45 mins.\nAll in all, not a memorable stay & would not like to stay here for my next business trip.\n
I have stayed at this hotel many times (5-6 trips of a week each). I have always been extremely impressed by the courtesy, hospitality and professionalism. The food is also terrific. In Karachi you have to expect a certain level of background disruption due to power outages, monsoons, street violence, etc. But at the MariottI have confidence that with their backup power systems, security, etc, I will be safe and comfortable. Because of I would rate them higher than the many good hotels I've stayed at in the US. I know they will take care of me even in those little 'emergencies'.


text:
Welcome to Total Film's 100 Greatest Movies! To compile this list we trawled through our back catalogue of issues - 13 years worth - and picked out all of our 5-star reviews in search of our top 100 films.
In those 13 years, 160-some films were regarded worthy of a 5-star review, and after some cutting, whittling and massaging (Talladega Nights anyone?), we've culled that original shortlist down to the one hundred five-star reviews we think represent the 100 Greatest Movies.
If a film isn't on the list, it may mean that we haven't reviewed it in our tenure, or that for some reason we only gave it a 4-star review.
For films that came out before 1997, we've relied on the DVD review, for films post-1997 that have both cinema and DVD reviews, we've used the original cinema review (hence no Hidden - criminally given only 4-stars on release).
And lastly, this list is not a count-down, it's alphabetical - we're not playing favourites here.
So sit back, and scroll and click your way through our 100 Greatest Movies, and no doubt leave us a comment about something not being included...
2001: A Space Odyssey
All About Eve
American Graffiti
Annie Hall
The Apartment
Apocalypse Now
Next: Back To The Future, Badlands, Bambi[page-break]
Back To The Future
The Battle Of Algiers
Belle De Jour
The Bicycle Thieves
The Big Lebowski
Black Narcissus
Blade Runner
Blue Velvet
Next: Bonnie And Clyde, Boogie Nights, Brazil[page-break]
Bonnie And Clyde
Boogie Nights
The Cabinet of Dr Caligari
Cinema Paradiso
Citizen Kane
City of God
The Conversation
The Dark Knight
Next: Das Boot, The Deer Hunter, Die Hard[page-break]
Das Boot
The Deer Hunter
Die Hard
Dirty Harry
Donnie Darko
Don't Look Now
Double Indemnity
Dr Strangelove
ET: The Extra-Terrestrial
The Exorcist
Next: Fargo, Fight Club, Finding Nemo[page-break]
Fight Club
Finding Nemo
Glengarry Glen Ross
The Godfather
Gone With The Wind
Half Nelson
Next: Halloween, Heat, His Girl Friday[page-break]
His Friday Girl
It's A Wonderful Life
King Kong
L.A. Confidential
Lawrence Of Arabia
The Lord of the Rings Trilogy
Next: Manhattan, Metropolis, Miller's Crossing[page-break]
Millers Crossing
Monty Python's Life Of Brian
Night Of The Living Dead
No Country For Old Men
North By Northwest
One Flew Over The Cuckoo's Nest
Next: The Passion Of Joan Of Arc, Persona, Psycho[page-break]
The Passion of Joan of Arc
The Philadelphia Story
Pulp Fiction
Raging Bull
Raiders Of The Lost Ark
Rear Window
Reservoir Dogs
The Seventh Seal
Next: Sideways, Sin City, Singin' In The Rain[page-break]
Singin' In The Rain
Some Like It Hot
Star Wars Ep IV: A New Hope
Star Wars Ep V: The Empire Strikes Back
Sunset Boulevard
The Sweet Smell of Success
There Will Be Blood
The Third Man
Next: This Is England, This Is Spinal Tap, Tokyo Story[page-break]
This Is England
This Is Spinal Tap
Tokyo Story
Touch Of Evil
The Truman Show
West Side Story
When We Were Kings
Withnail and I
The Wrestler
Agree? Disagree? Leave us a comment!


text:
Message Board
Hermann Hesse Message Board
Talk about the novels, new and used books that Hesse has written!
Author Hesse's Book Reviews
Beneath the Wheel
An intellectual gifted boy goes to a prestigious boarding school and meets a rebellious friend who changes his outlook on life. Hans Giebenrath is a gifted student who has to decide what he wants out of life. At the beginning of the book, Hans lives in a small town in Germany with his father, who puts a lot of pressure to study and do well on his exams, in order to be accepted to a prestigious boarding school. Hans is nervous about doing well on his ex...
With World War I looming, Emil Sinclair begins a "coming of age" journey in his small town. He fights his internal fears at the hands of the school bully, Franz Kromer. He revolts against his proper upbringing at the urging of a new acquaintance, Max Demian. Max Demian invites Sinclair into a new realm of thought, teaching him the virtues of revolting against conventional thought, and provoking in him the confidence to think and act for himself....
Narcissus and Goldmund
This novel, set in the middle ages, follows the lives of two close friends whose lives take them on differing paths. Narcissus is the devoutly spiritual monk. He values his self-reflective cloistered life of scholarly study and worship. He is neither willing nor wanting to venture from the regimented and ordered life in the monastery. His best friend, Goldmund is restless with his life so he sets out to wander the world and to find meaning in the phy...
Siddhartha is a young man living with the Brahmin. While he is supposed to continue his life inside the community, Siddhartha, who is searching for spiritual enlightment, decides to leave the community with his best friend, Govinda. In his attempts to find enlightment, Siddhartha becomes homeless. He fasts and mediates, trying to reach enlightment in the most common way in India, but once again fails. He and Govinda also meet Buddha, but while Govinda d...
Hesse booklist
Steppenwolf is the story of Harry Haller, a recluse among society who feels his existence has become a heavy burden. He rents a room from a middle aged woman and her nephew, where he resides for six to eight months. He has very little to do with the pleasures of life, and spends most of his days in his room with his books, and most of his nights in lonely taverns. Though he is an intelligent man who once had many stimulating conversations with noble scho...
The Glass Bead Game
Joseph Knecht grows from an unassuming child to the leader of an esoteric order that exists to demonstrate the true nature of reality to the world. At some time in, centuries in a future, a young boy named Joseph Knecht is recruited to study within the austere order of the Castalians. All members of the order are boys and are brought in as young children. The boys study a diversity of intellectual, philosophical, and artistic topics in the hope that they...
Under the wheel
Hans Giebenrath is a boy who lives with his father in a small town. This boy is very intelligent and he is preparing for the exams of a religion school. He was second in the exams of the elite of Germany and so he was allowed to fulfill his dream and enter the school. But in the school he realised that what he wanted was not to be the best, but to find a true friend. The whole society tried to make him abandon the friendship and to make him concentrate o...


text:
Brevard, N.C. - The Brevard College Student-Athlete Advisory Committee teamed up with the Make-A-Wish Foundation this past year to help bring hope, strength and joy to children with life-threatening medical conditions.
"The Make-A-Wish Foundation is a great organization and we are very privileged to have worked with them on a year to year basis," commented Brevard College Senior Women's Administrator, Britne Stubbs. "With the dedication and determination of our SAAC members this year, I know we will continue to impact lives throughout the nation."
The BC SAAC raised $587.01 for the Make-A-Wish Foundation during the 2009-2010 athletic year and will team up again with Make-A-Wish in the 2010-2011 year.
Since 1980, the Make-A-Wish Foundation® has enriched the lives of children with life-threatening medical conditions through its wish-granting work. The Foundation's mission reflects the life-changing impact that a Make-A-Wish® experience has on children, families, referral sources, donors, sponsors, and entire communities.
To learn more about Make-A-Wish, go to www.wish.org.


text:
'It's the Sabres that pose the biggest threat to the Canes' chances. Not only because guys like Daniel Briere, J.P. Dumont, and Ales Kotalik are incredibly talented, and Chris Drury exemplifies hard work and leadership, but because the Sabres epitomize everything that is great about the National Hockey League. They work hard, don't quit, and battle you until the horn sounds.'
The Sabres Report - May 26, 2006


text:
Displaying items by tag: the buchanan boys
Issues surrounding the management of the country's national forests have always been thorny. It's easy to see why — there are numerous user groups that, on the face, often appear to be at odds regarding how national forests should be managed. The USDA Forest Service is charged with the stewardship of these national forests and it is, by and large, a thankless task.


text:
Scenes from the Philadelphia Tattoo Convention 2013
Today kicked off the start of one of the largest and most popular tattoo conventions in the country - the Philadelphia Tattoo Convention. Some attendees showed off both old and new tattoos, while others bore their skin for some fresh new ink. Over 200 world famous tattoo artists will be at the Pennsylvania Convention Center all weekend long. Doors open from 11 AM - 12 AM on Saturday, February 9th, and from 11 AM - 8 PM on Sunday, February 10th.


text:
Puddle of Mudd singer arrested accused of battering ex-wife
Listen to Puddle of Mudd on iHeartRadio
(TMZ) - Puddle of Mudd singer Wes Scantlin was arrested in L.A. last night after cops say he roughed up his ex-wife in front of several witnesses, TMZ has learned.
Law enforcement sources tell TMZ that police were called to a business in West Hollywood around 3:30 pm after someone reported Scantlin shook his ex-wife and then tried to drag her by the arm or the shirt.
TMZ reports that when cops arrived, deputies spoke with witnesses and the victim - and decided to arrest Scantlin for domestic violence.
Scantlin was extremely uncooperative during the arrest, and one source tells TMZ, "He was very mouthy."
Sources tell TMZ Scantlin - who penned the hits "She Hates Me" and "Blurry" - is currently in custody and bail has been set at $20,000.
It's been a rough month for Scantlin, who was arrested on May 7 on warrants stemming from his cocaine case.
Photo Credit Getty Images


text:
Every person is surely seeking the high-quality furniture for their own house. Furniture is one thing that makes our house a home. So, it means that furniture is not something that we can take for granted. The greatest furniture sets should...[Read More]
When people talk about the comfortable place, some people of course say if comfortable place is in their own home, but why? Yeah, people will feel enjoy in their own home, especially when they have big lots furniture. This kind of furniture...[Read More]
Recent Posts
Our Partner
Popular Design
Get Connect
Home | About | Contact | Sitemap | Topics | Privacy Policy | Term of Service | Copyright/IP PolicyCopyright © BIEICONS.COM 2012 – All Rights Reserved.


text:
It has been four years in the making, but pictures from the BBC's new nature documentary Africa are finally here.
Narrated by Sir David Attenborough, the series covers the whole continent, exploring remote corners of mountains, deserts and the sea.
It features everything from great white sharks at feeding time to families of meerkats and the annual meeting of eight million bats.
- More about:
- David Attenborough
- Wildlife


text:
Your shopping cart is empty!
Nike Arsenal 2005 Official home shirt in red/white/yellow.Features embroidered team badge and logo,Felt placed sponsor in front.Mesh panels throughout for breathability.100% polyester.Comes with official licensed palyer N&N of Reyes #9 in PU version and EPL badge in PU .
Note:All of our Products are official,brand new with its original tags.
|Name and Number
Soccerplus first opened in 1994. We were one of the first soccer websites to hit the webView more
Address: 1640 E. Washington Blvd.
Pasadena, Ca 91104, USA
Phone: 1-800-945-7291
Get Direct


text:
Discuss football with over 60,000 fans. Free Membership.
Join now
Log in to check your private messages
Log in
FootballsFuture.com Home
My Guaranteed 2013 Mock Draft (Updated 04/04 bottom pg 1)
Goto page
FootballsFuture.com Forum Index
San Francisco 49ers
View previous topic
View next topic
Joined: 03 Jan 2006
Posts: 13968
Location: Lancaster, PA
Posted: Sun Apr 29, 2012 11:11 am
Post subject: My Guaranteed 2013 Mock Draft (Updated 04/04 bottom pg 1)
Well, with the 2012 NFL Draft in the books, our attention as a draft related website can start to shift focus to the 2013 prospects. Looking at next year's list, and what I expect from our team, I feel 100% confident in guaranteeing the following draft:
Round 1, Pick 32:
Some Guy Nobody Expected to be an Option, Position of Need, Some School
When Some Guy Nobody Expected to be an Option's name is called, our collective jaws will drop. Here's a guy that probably would have been available at least 10 picks later, making us extremely curious as to why we reached for him, but Baalke does this kind of thing to us all the time, and an article that comes out after the pick suggests that the very next team was seriously considering the same player, even though nobody had thought that was true even a day before. Every single mock draft but this one becomes irrelevant, as they are all completely wrong. No less than 3 posters on this forum complain like the sky is falling and grade the pick an "F." Half the rest of the posters give the grade a C because of the options that were passed on, and the other half give it a hopeful "B" or "B+," not because they like the pick, but because they're trying desperately to believe in Baalke and justify the pick in their heads at the same time.
Round 2
A Player that Nearly Everyone Likes But Can't Figure Out How He Fits on this Team, Position with Established Starter, A Different University
After a full day of talking about the better options than the first round pick, the lot of us create a list of prospects we're hopeful will fall to our pick, or that we may have the brass balls required to trade up and grab. We get on the clock, and a handful of those players are available. Suddenly, A Player that Nearly Everyone Likes But Can't Figure Out How He Fits on this Team's name is called, and we're all like "Wow!" We rush to the forum to find a half dozen posters already super excited about the possibilities, the other half liking the player, but trying to figure out why he was picked over others that were larger needs. At least one poster hates the pick, because he had already posted about the sky falling previously yesterday, and now the same prospect he wanted in Round 1 is still available at the pick in Round 2, and we skipped them again. Same poster makes a sky is falling topic, comparing us unfavorably to something else in a way to make it seem like it was the worst draft of all-time. Everyone else says it's an overreaction, including y2. y2, however, is called out for protecting his friends. I don't know why this happens, but rest assured - it will.
Round 3, First Pick:
Player that Nobody Likes at All That Most Believe Was a Sixth Rounder, Position of Major Need, WTFU
Assuming we didn't start a series of trade downs that will unbelievably net us 5 extra draft picks combined between this draft and next (one of which will inexplicably be a higher pick than we originally started with), we draft a guy that sends the forum in a frenzy. Nobody likes the pick. Well, not 'nobody' - one or two posters who don't really like the pick will defend the pick against being a reach using logic that doesn't really seem to work, but a few people will accept anyway. The whole forum really hates the pick given the dozen or so better options (according to the draft experts) at the same position still readily available. The poster who started the thread after the 2nd round pick was made's head explodes and is never heard from again (until the inevitable 'Grade our Draft' thread is made - just can't stay away from that one...even without a head!)
Round 3, Pick 2:
The First Pick Generally Everyone Agrees With, Position of Need, Respected University
And here it is - right before the end of Day 2, we end up with our most agreeable pick - a guy who most thought would be available around this time at a position we hadn't addressed yet gets picked up, and the board lets out a collective sigh of relief. Amazingly, this prospect was in absolutely no one's mock drafts leading up to the draft, but after how off-the-wall the other picks had been, this one somehow seems like a savior. Except to the guy who's head exploded - he will still somehow hate this pick in the 'Grade our Draft' topic. Absolutely best case scenario - the pick is so good that he can't REALLY hate it, so he leaves it out of the discussion entirely as is perfectly counters his point.
Round 4:
Nondescript Player #1, Position, MEH
After mourning the loss of a dear poster who we are somewhat unaware will resurrect later in the 'Grade our Draft' post, we compile the list of the best remaining prospects. These consist of players who are falling due to injury, character, or poor Senior Bowl showings, and most agree they were probably on the cusp of being third rounders. When our pick comes up...all of them are still there. Being it's the fourth round, and a lot of the picks seem anticlimactic, when Nondescript Player #1's name is announced, most of us don't even realize it happened. Some casually look over his draft profile and say "Eh, he's a body" and the rest of us disappear until our fifth round pick, because really - posting about this guy seems like a waste of time.
Round 5:
No Name Prospect That we Trade up 20 or so Spots for, Position of Need, Division 6 school
Suddenly, about 20 spots ahead of our first of two fifth round picks, we see the 49ers are on the clock again. The excitement starts building! Of those prospects that were on the cusp of the third round that were available previously....ALL are still somehow available. It's time for value! Then the pick is announced...and nobody knows who it is. The experts search for pronunciation guides to announce his name correctly, the draft websites try and search for information as to why the prospect was never even listed on their site, half of us go and try and research the school that we thought was one of the fictional schools they used as a joke in
The Waterboy
. Nobody sensible can really hate the pick because it was a fifth rounder for one, and two there's no idea on if this player is any good or not. A few of us huddle in a corner and cry a little, but we don't post about it because it hurts our forum cred. We learn we gave up our other fifth and a sixth to make it happen. No clue why.
...oh, and in 2014, this guy is listed as the incumbent starter at his position despite never playing a down in 2013. Just a head's up.
Round 6:
Nondescript Player #2, Position, Random ACC School
After being emotionally drained by the previous...well let's not beat around the bush, by the entire draft, when Nondescript Player #2's name is called there's hardly any way much enthusiasm can be generated. One or two posters will get behind the pick because they want a favorite player from the draft, and others will just because they're thrilled they actually watched one quarter of a game the ACC school played in the previous season while waiting for a better game to start. They don't recall noticing the player do anything, but at least it's better than a Division 6 school. One or two posters will actually find a way to hate the pick, because it came at the same position as another prospect that they really liked, and was at one time considered a 2nd round prospect. Somehow, that guy goes undrafted.
Round 7, Pick 1:
Taylor Mays, S, USC
Really, when it comes down to it, there's no way anyone's going to really like this pick, because we're all going to remember that in 2010, it was our 2nd round pick...and Mike Singletary wasted it. The guy we get won't likely even make the practice squad, so it may as well be drafting Taylor Mays a second time. Thanks a lot, Mike Singletary! y2 then sighs heavily when all the posts made referencing how this nobody we drafted was really Taylor Mays are posted, because he realizes his incredibly early 2013 guaranteed mock draft really laid the seeds for this discontent with the pick, and now he has to deal with all the posts referencing it. Smart move y2. Here would be a good time to edit the pick...but you're not going to. Lazy jerk.
Round 7, Pick 2:
Nondescript Player #3, Defensive Back, A school that sounds small but isn't
Our 7th round pick is picked specifically so he can work on special teams, and with our great unit - he actually looks really good! But that's all he ever is, so he's really just any other 7th round pick.
(Sorry for the lack of pictures - you wouldn't believe the dearth of them available for these guys)
Future Hall of Famer Frank Gore's Career Rushing List Tracker:
*Currently Ranked 8th All-Time
*Yards needed to pass #7 Eric Dickerson: 194
*Yards needed to pass #6 Jerome Bettis: 597
Last edited by y2lamanaki on Thu Apr 04, 2013 3:06 pm; edited 1 time in total
Back to top
Joined: 24 Oct 2006
Posts: 43425
Posted: Sun Apr 29, 2012 11:34 am
Post subject:
Love when y2 finds too much time on his hands and isn't arguing something to death by insulting the opponent's intelligence!!! Awesome!
Half the rest of the posters give the grade a C because of the options that were passed on
I definitely fall into this category for this draft selection. I am really disappointed that prospect Z/man-crush LB4 from 7TF actually fell to us and we PASSED on him! All for some dude I had graded out as a round 3 option! But I will hold out hope... knowing that our F/O has been wise and competent in the past.
By round 2, I was hungover... still heart-broken, and rather defeated at this point.. So it was no surprise that we selected 42Nb from KY2D. Didn't see this coming at all... and the rest of the picks are all questionable.
Oh well... life goes on. Now, is where I will swear off ever spending so much time researching draft prospects... while suspecting all along that I'll be giving just the same effort after the 2012 season is completed.
Back to top
Joined: 18 Jan 2007
Posts: 7946
Location: Indiana
Posted: Sun Apr 29, 2012 11:35 am
Post subject:
best mock ever
Back to top
Joined: 13 Nov 2007
Posts: 24654
Posted: Sun Apr 29, 2012 1:01 pm
Post subject:
This is getting bookmarked, then will be grave dug in a year.
Back to top
Joined: 15 Mar 2008
Posts: 4528
Location: Marin County, CA.
Posted: Sun Apr 29, 2012 2:25 pm
Post subject:
Brilliant! As the general consensus is the kiss of death, we all can go into next years draft predicting our selections based on the template above. Then the consensus will be the abstract selections resulting in a draft full of prospects that we all secretly like.
Back to top
Joined: 21 May 2008
Posts: 9201
Location: El Paso
Posted: Sun Apr 29, 2012 3:31 pm
Post subject:
You win at life.
Back to top
Joined: 03 Jan 2006
Posts: 13968
Location: Lancaster, PA
Posted: Wed Feb 27, 2013 12:08 pm
Post subject:
So everyone knows - I'm sticking by my mock. Also a bump for anyone who may have missed it the first time.
Future Hall of Famer Frank Gore's Career Rushing List Tracker:
*Currently Ranked 8th All-Time
*Yards needed to pass #7 Eric Dickerson: 194
*Yards needed to pass #6 Jerome Bettis: 597
Back to top
Joined: 24 Oct 2006
Posts: 43425
Posted: Wed Feb 27, 2013 12:27 pm
Post subject:
oldman9er wrote:
Now, is where I will swear off ever spending so much time researching draft prospects... while suspecting all along that I'll be giving just the same effort after the 2012 season is completed.
Oh damn... my suspicion comes true yet again. Why?!? Why can I never find something actually useful to do with all of this time on my hands?!?
Back to top
Joined: 12 Mar 2007
Posts: 17054
Location: Québec
Posted: Wed Feb 27, 2013 12:33 pm
Post subject:
oldman9er wrote:
oldman9er wrote:
Now, is where I will swear off ever spending so much time researching draft prospects... while suspecting all along that I'll be giving just the same effort after the 2012 season is completed.
Oh damn... my suspicion comes true yet again. Why?!? Why can I never find something actually useful to do with all of this time on my hands?!?
Build a bird house? Fight crime at night?
RudyZ's Power Rankings Power Ranking
1) RudyZ's Power Rankings Power Ranking
2) y2's pie Power Rankings (3.1416 rules!)
3) N4L's Poster Power Rankings
Back to top
Joined: 03 Jan 2006
Posts: 13968
Location: Lancaster, PA
Posted: Wed Feb 27, 2013 12:39 pm
Post subject:
Borrowing Psychlone's idea and using this as a template, our draft might look something like this (compensatory picks not included, and including the 5th round up 20 spots trade as predicted in the original post):
1) Terrence Williams, WR, Baylor
2) Montee Ball, RB, Wisconsin
3/1) Cooper Taylor, S, Richmond
3/2) Joe Kruger, DE, Utah
4) Jordan Mills, OT, Louisiana Tech
5) Tony Tatum, CB, Gallaudet
6) Dustin Hopkins, K, Florida State
7/1) Dan Giordano, DE, Cincinnati (moved to OLB)
7/2) Tyrone Goard, WR, Eastern Kentucky
Future Hall of Famer Frank Gore's Career Rushing List Tracker:
*Currently Ranked 8th All-Time
*Yards needed to pass #7 Eric Dickerson: 194
*Yards needed to pass #6 Jerome Bettis: 597
Back to top
Joined: 24 Oct 2006
Posts: 43425
Posted: Wed Feb 27, 2013 12:42 pm
Post subject:
rudyZ wrote:
oldman9er wrote:
oldman9er wrote:
Now, is where I will swear off ever spending so much time researching draft prospects... while suspecting all along that I'll be giving just the same effort after the 2012 season is completed.
Oh damn... my suspicion comes true yet again. Why?!? Why can I never find something actually useful to do with all of this time on my hands?!?
Build a bird house? Fight crime at night?
The first one was a mistake, as my rabid dogs screamed at them incessantly.
The second one was a huge mistake, as I got beaten up badly by the biggest, meanest cross-dresser I'd ever encountered. How was I supposed to know? I thought I was preventing a rape, but their actions in that dark alley were consensual and I ruined her/his appointment.
Back to top
Joined: 03 Jan 2006
Posts: 13968
Location: Lancaster, PA
Posted: Thu Apr 04, 2013 3:05 pm
Post subject: s
Here's a mock I came up with - not having anything to do with the above referenced mock/template. Just an actual one I wanted to keep in this thread:
I start off with a trade: 49ers trade picks #31, #74, and #157 (from IND) to Chicago for pick #20.
1) Kenny Vaccaro, S, Texas -
First off, I know this is a pricey trade, but it would be about what is required to get it done, assuming neither side gets greedy, and I am going to attempt to justify it. In Mel Kiper's most recent mock (not someone I trust 100%, I just used it as a guide), he has Vaccaro skipping past the Rams at 16, and falling back to them at 22. First off, I don't believe they'll skip over him at 16, and I definitely don't believe he'd get past the Bengals at 21. However, I just went with the concept that the Rams would roll the dice and let him pass.
Then I look at our team, and as of this exact moment in time, the starting FS is someone in the Darcel McBath/Trenton Robinson/CJ Spillman/Craig Dahl mix. That assumes that nobody is transferring to FS of Rogers/Culliver/Brown/Nnamdi. That is slightly terrifying, in my view, and a reason I understand why some were so mad we let Goldson walk (though I still side with those that believe we just couldn't afford him here).
Vaccaro is far and away the best free safety option in the draft to have someone as a reasonable starter, and the dropoff after that is just too great, IMO. The idea of passing on him in favor of anyone who might be available at 31 or 34 (or *gulp* later) just doesn't seem worth a third and fifth round pick. I see the needs going into the draft as needing to replace Goldson, Sopoaga, and Walker, as well as finding depth at defensive line, linebacker, and pass-rusher. That's really it in the grand scheme of things. We're now reasonably set for 2013 at QB, RB, WR, OL, CB, and special teams, and I see FS, 2nd TE, pass-rushing OLB, and NT as the only positions where there's a reasonable shot at playing time. So the 3rd became expendable, and the 5th is a 5th...
2a) Zach Ertz, TE, Stanford -
I would have really liked to see Eifert fall down the boards, but that no longer looks as if it'd be the case. It still remains possible for Ertz, and he's far from just a consolation prize. He's an improvement over Delanie Walker, certainly at least from a receiving standpoint, and can make an immediate impact on the team. Plus, it gives our already suddenly strong offense an extra weapon.
2b) Jonathan Jenkins, NT, Georgia -
I've seen him fall to the 57-58 picks in the draft, so what's 3 more? A big NT could easily be depth right away at the position should the team feel more comfortable with Dorsey there, and if not, could challenge to be a starter.
3) Corey Lemonier, DE/OLB, Auburn -
Might be a pipe dream to get him to fall all the way to 93, but if he were there it'd seem crazy not to take him at this point. He has size similar to Aldon Smith when he came out of college (a few pounds lighter), and a fairly similar skillset. He's already rushed from the linebacker position in college, and seems to do better out of a 2-point stance anyway. Great mix of speed and power, could probably play the role Aldon did as a rookie as just a dedicated pass-rusher in pass-rushing situations. Certainly would provide great depth. Great motor and doesn't quit on plays, which is helpful for facing some of the new breed of QBs (especially in our division).
4A) Marcus Lattimore, RB, South Carolina -
I couldn't escape the thought of taking him even down a few picks due to my trade because he's just a special talent and reminds me so much of Frank Gore, which is ideal for when we need to replace Gore. Plus, as a Gators fan, I maintain a very clear SEC bias that may or may not show in my selections (may).
4B) William Gholston, DE, Michigan St.
A guy who certainly has great size for the position, but questionable consistency concerns. However, when he plays at his best, he'd be a great fit in the defensive line rotation, with the potential to be a starter down the road, but not someone I'd ever see in the Justin Smith replacement mold (sadly that waits another year - though Sheldon Richardson still remains someone I believe would be the perfect replacement, should we be able to afford moving up for him).
6A) Jonathan Stewart, ILB, Texas A&M
Not a bad guy to have for depth, as he can also play OLB in a pinch. Good instincts and nose for the ball. Clearly not needed to start unless there's an injury, and can act as a solid replacement for Gooden/Grant.
6B) Marc Anthony, CB, California
I've seen most draft sites list him as a 6th-7th rounder. Is this right? Outside of durability concerns, he's a solid player I would've expected as a mid-round guy. Still, because I can do what I want, I kept him as a '6th-7th rounder.' Works for me.
7A) Sam Brenner, G, Utah
A guard in college, we'll convert him to SS for our team.
7B) Cooper Taylor, S, Richmond
A safety in college, we'll convert him to OG for our team.
In all seriousness - taking a flier on this kid might be well worth it for some team. He's an impressive small school prospect (want to say he was originally with Georgia Tech, but uncertain).
7C) Caleb Sturgis, K, Florida
I know we signed Dawson already, but if he's here - why not, right?
Future Hall of Famer Frank Gore's Career Rushing List Tracker:
*Currently Ranked 8th All-Time
*Yards needed to pass #7 Eric Dickerson: 194
*Yards needed to pass #6 Jerome Bettis: 597
Back to top
Joined: 18 Jan 2007
Posts: 7946
Location: Indiana
Posted: Thu Apr 04, 2013 3:30 pm
Post subject:
It doesn't get better than that.. Vacarro is an instant starter, Ertz provides a possible upgrade over Delanie.. Great competition for depth all throughout the rest...
Back to top
Joined: 26 Feb 2007
Posts: 19733
Posted: Thu Apr 04, 2013 4:15 pm
Post subject:
If you've been reading my recent comments on the draft I think you know that I would find this almost perfect. Don't know much about many of the later picks, but after the first part of this mock everything else is just icing on the cake.
What's more I think this is exactly the sort of thng we might do. Your reasoning on Vaccaro is spot on; S and TE and DE will be our three biggest priorities with S at the top of the list and Vaccaro stands out in the list of guys available. You do have to worry about Dallas though.
Back to top
Joined: 09 Jan 2007
Posts: 10131
Location: NY
Posted: Thu Apr 04, 2013 4:35 pm
Post subject:
I would love love love this draft!
BlaqOptic wrote:
Dan Connor is twice the LineBacker that "PWilly" will ever be.
Back to top
Display posts from previous:
All Posts
1 Day
7 Days
2 Weeks
1 Month
3 Months
6 Months
1 Year
Oldest First
Newest First
FootballsFuture.com Forum Index
San Francisco 49ers
All times are GMT - 4 Hours
Goto page
Jump to:
Select a forum
NFL General
NFL News
NFL Comparisons
NFL Draft
2017 NFL Mock Draft
GM Mock Drafts
Fantasy Football
College Football
AFC East
Buffalo Bills
Miami Dolphins
New England Patriots
New York Jets
AFC North
Baltimore Ravens
Cincinnati Bengals
Cleveland Browns
Pittsburgh Steelers
AFC South
Houston Texans
Indianapolis Colts
Jacksonville Jaguars
Tennessee Titans
AFC West
Denver Broncos
Kansas City Chiefs
Oakland Raiders
Los Angeles Chargers
NFC East
Dallas Cowboys
New York Giants
Philadelphia Eagles
Washington Redskins
NFC North
Chicago Bears
Detroit Lions
Green Bay Packers
Minnesota Vikings
NFC South
Atlanta Falcons
Carolina Panthers
New Orleans Saints
Tampa Bay Buccaneers
NFC West
Arizona Cardinals
Los Angeles Rams
San Francisco 49ers
Seattle Seahawks
Other Sports
Other Sports
Fantasy/Sim/GM Leagues
This aint sports talk!
Madden 17 and video games
Feedback Forum
Signature and Avatar Help
post new topics in this forum
reply to topics in this forum
edit your posts in this forum
delete your posts in this forum
vote in polls in this forum
Powered by
© 2001, 2005 phpBB Group


text:
2 Chainz arrested after tour bus standoff
Listen to 2 Chainz on iHeartRadio
(Upadate - 12:37 PM PT) - 2 Chainz just tweeted, "This sh*t will make u go crazy, our bus gets pulled 1 a week and they always say I smell weed I need to search ur bus. Sh* gets tiring"
12:30 PM PT - Law enforcement sources tell TMZ, drugs WERE found on the bus ... but they wouldn't specify which, or how much.
(TMZ) - Rapper 2 Chainz was on board the tour bus involved in a police standoff in Oklahoma last night ... and he's already been arrested in connection with the incident, reports TMZ.
TMZ broke the story that 2 Chainz' tour bus was pulled over in OKC around midnight after police noticed its taillights were out. When they approached the vehicle, cops say they noticed signs of drug use and attempted to board the bus.
But the bus driver locked the police out, insisting they obtain a warrant first.
Police did just that and eventually entered the bus hours later, where they arrested 11 passengers for "interfering with the police process," including 2 Chainz.
It's unclear if they face additional charges.
Photo Credit Splash News


text:
Results 1 to 3 of 3
31st October 2012 09:55 PM #1
- Join Date
- Sep 2012
- Posts
- 3
was using furniture antibacterial wipes on my skin
hi im 31 weeks pregnant for the last 2weeks i have been using antibacterial wipes on my skin i thought it was for hygiene but as i have just re read the packet they are for removing grim etc for kitchens and things could i have harmed my unborn baby by using these wipes im freaking out ?
4th November 2012 10:49 AM #2
- Join Date
- Jan 2012
- Posts
- 1,936
The skin does absorb nutrients and toxins from whatever you put on it. The rate of absorption can depend upon which area of the skin you were using the wipes on (i.e. hands, face, arms, etc.).
The best thing would be to stop using any antibacterial products on your skin and just use soap and water. You may also want to be sure you are drinking green smoothies and eating as many fresh fruits and vegetables as possible. The more greens you get into your body the easier time your body will have of moving toxins out of your system. You don't want to do a heavy cleanse while pregnant, but eating greens and drinking fresh juices is a benefit.
How are you feeling now that you are 31 weeks along?
Warm Regards,
4th November 2012 05:03 PM #3
- Join Date
- Dec 2011
- Posts
- 532
It is probably nothing to worry about. There is nothing you can do to go back in time and the stress is likely more damaging for your baby than the wipes. Follow Kate's suggestions, eat immune boosting foods and stick to simply using warm water and soap from this point on. Even antibacterial solutions intended for use on skin are questionably safe or necessary.


text:
Welcome | Issues Update | Upcoming Events | Resources | Contact Us | Donate
Families of September 11 is now operating as the For Action Initiative. The web pages on this site are available for informational purposes only. Please visit us at www.foractioninitiative.org.
WelcomeWe approach spring with a renewed sense of hope that we can both heal and help make a difference. We urge you to avail yourselves of the helpful TOOLS section, read contributions from our members and other interested parties and keep updated on news and resource information.
Issues Update
This has been a very busy month for the 9/11Commission. FOS11 was pleased that the Commission had secured the public testimony of Dr. Condoleezza Rice on April 8. Dr. Rice's testimony raised some serious issues which we are hopeful the Commission will continue to pursue. In the days following the hearings, the Administration released the often-cited August 6th Presidential Daily Briefing http://www.agonist.org/annex/pdb.htm.
This month's hearings have concluded with the testimony of top-level law enforcement and intelligence officials past and present as well as Attorney Generals Janet Reno and John Ashcroft. Copies of all the staff statements and witness testimony are available through the Commission's website at www.9-11commission.gov.
The full text of the hearing, including all questions and answers, spoken remarks, etc can be viewed at http://www.nytimes.com/2004/04/13/politics/14TEXT-COMPLETE.html.
Lower Manhattan – Updates
Personal Property Update
Listing of Names on the Memorial at Ground Zero
A Poem for the Families
Upcoming Events
Families of September 11 Wilderness Hike – We hope to see you on our 3rd hike!
Sending Letters of Support to Families in Madrid after 3/11
Family Hike in Massachusetts on April 23rd
Comfort Zone Camp – Openings Remain for the April 23rd-25th Weekend
Art For Heart First Sundays – Children's Event on May 1st in New York City
Essay Contest for High School, College and Graduate Students in the USA & Canada
Volunteers Needed
Support Needed
Tips Regarding the September 11 Victim Compensation Fund
Important Advisory from the FDA on Depression
Song and Free CD for 9/11 Families
Family Member Photo Albums
Graduate Student solicits 9/11 Family Input for Thesis
FOS11 offers a wrist band, in hope for a better future. Click here to learn more.
Contact Us


text:
On the Shelf
February's Shocking Secret, and Other NewsBy Dan Piepenbring
- You won't BELIEVE February's dirty, hidden past! "Before we adopted the Latin name for the second month, Old English used much more vibrant names to describe it. The most common Old English name was Solmonath, which literally means 'mud month.'"
- You won't BELIEVE what a steady dose of antidepressants and benzodiazepines did to this writer's creativity!
- You won't BELIEVE who offered these kind, pizzalicious words about our magazine! "I have every issue of The Paris Review, and I only read them when I feel like I've worked really hard and deserve a reward. It's like New York pizza—hard to find a bad slice."
- You won't BELIEVE how far your jaw drops when you look at these eleventh-century illustrations of the Book of Revelation!
- You won't BELIEVE how this parrot helped solve a crime in India! "Whenever Ashutosh's name was mentioned, the parrot would start screeching."
- You won't BELIEVE how lame this writerly T-shirt is!


text:
Chapel Gathering -" Church as a Healing Space: further reflections"
When Tuesday February 12, 2013 @ 11:00 AM (1624 days ago)
Where Seminary, 215, Martin Chapel
Duration 45 minutes
Dr. Michael King, EMS Dean.
The entire campus community is invited to every chapel worship service on campus.
Eastern Mennonite Seminary hosts chapel gatherings in Martin Chapel every Tuesday
and Thursday; EMU Campus Ministries hosts chapel gatherings every Wednesday and
Friday in Lehman Auditorium.
Intended Audience General Public
Contact Information
Name Seminary
Phone # 540.432.4260


text:
Creative Writing and Literature 388. Advanced Playwriting
After we've written one or two plays, what we have to hold onto in those terrifying moments of facing the blank page are more refined instincts; a sharper sense of immediacy; some tools for creating character, dialogue, setting and dramatic arc, and probably a stronger determination to make the beast fly. Through a series of writing exercises and an ongoing discussion of individual creative process, we will focus on developing, shaping, refining and energizing our content. Plays written in this course will be included in the annual spring New Plays Festival. Readings of contemporary plays, theory, manifestos and reviews will supplement our creative work.


text:
'"It's a big upgrade," Buffalo Place Executive Director Michael Schmand said during the downtown business district group's monthly board meeting Wednesday. "We need to thank the Sabres."'
Archives for May 2012
Sabres thanked for gift of soil, sod
Thursday's Rochester Coverage
Sean McMorrow sentenced to 24 months in federal prison (Rochester D&C)
Sunday's Rochester Coverage
The dual lives of Sean McMorrow, former Amerks tough guy (Rochester D&C)
Friday's Rochester Coverage
Season rewind with defenseman T.J. Brennan (Amerks.com)
What Advanced Stats Say about the Sabres Pt. 4: Luke Adam
'It still remains a mystery why Lindy Ruff decided on Nov. 12 to remove Adam from his line with Pominville and Vanek. He was producing and the team was winning. Adam's glaring flaws were his ineffectiveness on the power play and weak puck possession numbers, which may reflect his poor defensive play. But Ruff was using him correctly, starting him largely in the offensive zone, putting him in a position to do what he does best. Even if he was a liability in the D-zone, Adam was plus-1 in the first 15 games.'
Off-Season Game Plan: Buffalo Sabres
'Upgrading the number one centre spot won't be easy, but it's a reasonable objective going into the offseason since the Sabres have a significant number of assets (including prospects and picks) to make a deal.'
Tuesday's Rochester Coverage
Paul Szczechura to play hockey in Europe (Rochester D&C)
Sulzer, Sabres renew acquaintances
'"We were surprised, pleasantly surprised, with his play."'
Sabres re-sign defenseman Sulzer
'"I think he played very well with Christian," Sabres general manager Darcy Regier said Monday inside the First Niagara Center. "I think … you really noticed his composure out there, his ability to not only break up plays – which is the most important thing defensively – but to make plays offensively and the patience that he showed."'
Sabres sign defenseman Sulzer for one year
'Sulzer played in 15 games with Buffalo last season after being acquired from the Vancouver Canucks, along with forward Cody Hodgson on Feb. 27. Sulzer, who had three goals and eight points with the Sabres, also appeared in 12 games with the Canucks last season, collecting one assist.'
Sabres sign D Sulzer
'Sulzer was acquired by Buffalo on February 27 along with forward Cody Hodgson in exchange for defenseman Marc-Andre Gragnani and forward Zack Kassian.'
Sulzer's back for another year
'This signing gives them eight NHL defensemen if you count Brayden McNabb. This now gives Regier more flexibility as he looks to makes moves.'
Sabres Regier updates off season progress
'So with all the discussions they've had in the almost two months since the season ended what have they come up with? Regier said, "We're going to look at the free agency market and it's a pretty small market, we'll look at the trades, we'll look obviously at the draft. I think that's where we'll see most of the activity going into free agency. The flexibility we have with the two first round picks, two second round picks and then we'll have a better understanding as we get closer to the draft as to what exactly is available on the market, outside of the free agency."'
How was Pominville's 1st year as captain?
'Lindy Ruff doesn't like strong willed captains that are in his face. He's had four of them in Drury, Briere, Michael Peca and Craig Rivet and he didn't like it. He would prefer players that are more laid back and do what they're told like Stu Barnes, Pominville and even Jochen Hecht who he almost made captain before Rivet.'
Sabres Sign Defenseman Alexander Sulzer
'Sulzer (6'1", 204 lbs, 5/30/84) collected eight points (3+5) in 15 games with the Sabres last season after being acquired from the Vancouver Canucks, along with forward Cody Hodgson on February 27. Sulzer also appeared in 12 games with the Canucks last season, collecting one assist.'


text: PBS always has something interesting waiting in the wings. This week, it will broadcast a trifecta of significant documentaries."The Revisionaries" (Independent Lens) 10 p.m. Monday (check local listings)Of all the films I have seen from PBS's Independent Lens series, "The Revisionaries" is the most unsettling. It confirms what I have heard and read over the last few years about the influence of fundamentalist Christians in public education through the narrow focus of c … [Read more...]